{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:18:39Z","timestamp":1785784719490,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Postoperative endophthalmitis is a rare but severe complication of cataract surgery. Intracameral moxifloxacin prophylaxis has been widely adopted, but concerns remain regarding bacterial resistance and clinical outcomes. This study aimed to evaluate the impact of intracameral moxifloxacin prophylaxis on endophthalmitis incidence, microbiological patterns, antibiotic resistance, and visual outcomes in a university hospital setting, with comparison to a private hospital cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study analyzed 21,178 cataract surgeries performed at a university hospital (2014\u20132023). The incidence of endophthalmitis, microbiological profiles, resistance patterns, and visual acuity outcomes (LogMAR) were assessed. Intracameral moxifloxacin prophylaxis was introduced in 2019. A comparative analysis was conducted with 19,360 surgeries from a private hospital. Fisher\u2019s exact test, Mann-Whitney U test, and Joinpoint regression were used for statistical analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Endophthalmitis incidence at the university hospital was 0.109% (23\/21,178 surgeries), significantly higher than the 0.021% incidence in the private hospital (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002). Post-prophylaxis, infection rates declined from 0.219% in 2016 to 0.042% in 2023 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003).\n                      <jats:italic>Staphylococcus epidermidis<\/jats:italic>\n                      predominated (52.6%), and moxifloxacin resistance remained stable (pre: 45.5%; post: no increase).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Intracameral moxifloxacin significantly reduced endophthalmitis incidence without increasing bacterial resistance. Post-prophylaxis infection rates aligned with national surveillance benchmarks (e.g., SES-SP threshold of 0.07%), reinforcing the efficacy of this preventive strategy in a public university setting. The worsening of final visual acuity post-prophylaxis underscores the need for continued clinical vigilance. Ongoing microbiological surveillance remains essential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-026-00845-y","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:27:56Z","timestamp":1775561276000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intracameral antibiotic prophylaxis and surgical expertise: key determinants in endophthalmitis after cataract surgery"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0154-9623","authenticated-orcid":false,"given":"Vinicius","family":"Campos Bergamo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6847-6748","authenticated-orcid":false,"given":"Luis Filipe","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4093-6818","authenticated-orcid":false,"given":"Nilva Simeren Bueno de","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1511-8696","authenticated-orcid":false,"given":"Caio Vinicius","family":"Saito Regatieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2220-7603","authenticated-orcid":false,"given":"Ivan","family":"Maynart Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9448-8742","authenticated-orcid":false,"given":"Mauro","family":"Silveira de Queiroz Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0338-3951","authenticated-orcid":false,"given":"Ana Luisa","family":"Hofling-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7034-8091","authenticated-orcid":false,"given":"Maur\u00edcio","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"845_CR1","first-page":"95","volume":"9","author":"K Vaziri","year":"2015","unstructured":"Vaziri K, Schwartz SG, Kishor K, Flynn HW Jr. Endophthalmitis: state of the art. Clin Ophthalmol. 2015;9:95\u2013108.","journal-title":"Clin Ophthalmol"},{"key":"845_CR2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ajo.2010.04.010","volume":"150","author":"CC Wykoff","year":"2010","unstructured":"Wykoff CC, Parrott MB, Flynn HW Jr, Shi W, Miller D, Alfonso EC. Nosocomial acute-onset postoperative endophthalmitis at a university teaching hospital (2002\u20132009). Am J Ophthalmol. 2010;150:392\u2013e3982.","journal-title":"Am J Ophthalmol"},{"key":"845_CR3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.ajo.2005.01.025","volume":"139","author":"JJ Miller","year":"2005","unstructured":"Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Newton J, Miller D. Acute-onset endophthalmitis after cataract surgery (2000\u20132004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol. 2005;139:983\u20137.","journal-title":"Am J Ophthalmol"},{"key":"845_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jcrs.2009.01.002","volume":"35","author":"RD Ravindran","year":"2009","unstructured":"Ravindran RD, Venkatesh R, Chang DF, Sengupta S, Gyatsho J, Talwar B. Incidence of post-cataract endophthalmitis at Aravind Eye Hospital: outcomes of more than 42,000 consecutive cases using standardized sterilization and prophylaxis protocols: Outcomes of more than 42 000 consecutive cases using standardized sterilization and prophylaxis protocols. J Cataract Refract Surg. 2009;35:629\u201336.","journal-title":"J Cataract Refract Surg"},{"key":"845_CR5","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.ophtha.2006.08.038","volume":"114","author":"M Moshirfar","year":"2007","unstructured":"Moshirfar M, Feiz V, Vitale AT, Wegelin JA, Basavanthappa S, Wolsey DH. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series. Ophthalmology. 2007;114:686\u201391.","journal-title":"Ophthalmology"},{"key":"845_CR6","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.ophtha.2011.11.023","volume":"119","author":"L Keay","year":"2012","unstructured":"Keay L, Gower EW, Cassard SD, Tielsch JM, Schein OD. Postcataract surgery endophthalmitis in the United States: analysis of the complete 2003 to 2004 Medicare database of cataract surgeries. Ophthalmology. 2012;119:914\u201322.","journal-title":"Ophthalmology"},{"key":"845_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1590\/S0004-27492010000600007","volume":"73","author":"GB Melo","year":"2010","unstructured":"Melo GB, Bispo PJM, Regatieri CVS, Yu MCZ, Pignatari ACC, H\u00f6fling-Lima AL. Incidence of endophthalmitis after cataract surgery (2002\u20132008) at a Brazilian university-hospital. Arq Bras Oftalmol. 2010;73:505\u20137.","journal-title":"Arq Bras Oftalmol"},{"key":"845_CR8","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1017\/S0950268807009405","volume":"136","author":"R Dias","year":"2008","unstructured":"Dias R, Cani\u00e7a M. Trends in resistance to penicillin and erythromycin of invasive pneumococci in Portugal. Epidemiol Infect. 2008;136:928\u201339.","journal-title":"Epidemiol Infect"},{"key":"845_CR9","first-page":"851","volume":"255","author":"A Grzybowski","year":"2017","unstructured":"Grzybowski A, Brona P, Kim SJ. Microbial flora and resistance in ophthalmology: a review. Arbeitsphysiologie. 2017;255:851\u201362.","journal-title":"Arbeitsphysiologie"},{"key":"845_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ophtha.2008.09.039","volume":"116","author":"WV Hatch","year":"2009","unstructured":"Hatch WV, Cernat G, Wong D, Devenyi R, Bell CM. Risk factors for acute endophthalmitis after cataract surgery: a population-based study. Ophthalmology. 2009;116:425\u201330.","journal-title":"Ophthalmology"},{"key":"845_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ophtha.2019.08.026","volume":"127","author":"S Pershing","year":"2020","unstructured":"Pershing S, Lum F, Hsu S, Kelly S, Chiang MF, Rich WL 3rd, et al. Endophthalmitis after cataract surgery in the United States: A report from the Intelligent Research in Sight Registry, 2013\u20132017. Ophthalmology. 2020;127:151\u20138.","journal-title":"Ophthalmology"},{"key":"845_CR12","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/antibiotics11070843","volume":"11","author":"X-N Wu","year":"2022","unstructured":"Wu X-N, Chen Y-H, Sharief L, Al-Janabi A, Al Qassimi N, Lightman S, et al. Emerging antibiotic resistance patterns affect visual outcome treating acute endophthalmitis. Antibiot (Basel). 2022;11:843.","journal-title":"Antibiot (Basel)"},{"key":"845_CR13","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ophtha.2017.01.026","volume":"124","author":"A Haripriya","year":"2017","unstructured":"Haripriya A, Chang DF, Ravindran RD. Endophthalmitis Reduction with Intracameral Moxifloxacin Prophylaxis: Analysis of 600 000 Surgeries. Ophthalmology. 2017;124:768\u201375.","journal-title":"Ophthalmology"},{"key":"845_CR14","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jcrs.2019.04.018","volume":"45","author":"A Haripriya","year":"2019","unstructured":"Haripriya A, Chang DF, Ravindran RD. Endophthalmitis reduction with intracameral moxifloxacin in eyes with and without surgical complications: Results from 2 million consecutive cataract surgeries. J Cataract Refract Surg. 2019;45:1226\u201333.","journal-title":"J Cataract Refract Surg"},{"key":"845_CR15","doi-asserted-by":"publisher","first-page":"e000609","DOI":"10.1136\/bmjophth-2020-000609","volume":"6","author":"S Bhatta","year":"2021","unstructured":"Bhatta S, Pant N, Poudel M. Postoperative endophthalmitis with and without intracameral moxifloxacin prophylaxis in a high volume surgery setting. BMJ Open Ophthalmol. 2021;6:e000609.","journal-title":"BMJ Open Ophthalmol"},{"key":"845_CR16","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA). Nota T\u00e9cnica GVIMS\/GGTES\/DIRE3\/ANVISA n\u00ba 05\/2025: Orienta\u00e7\u00f5es para a vigil\u00e2ncia das endoftalmites relacionadas aos procedimentos oftalmol\u00f3gicos invasivos [Technical Note on surveillance of endophthalmitis related to invasive ophthalmic procedures]. Bras\u00edlia: ANVISA; 2025. Available from: https:\/\/www.gov.br\/anvisa"},{"key":"845_CR17","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jcrs.2007.02.032","volume":"33","author":"ESCRS Endophthalmitis Study Group","year":"2007","unstructured":"ESCRS Endophthalmitis Study Group. Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33:978.","journal-title":"J Cataract Refract Surg"},{"key":"845_CR18","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jcrs.2013.06.014","volume":"39","author":"A Behndig","year":"2013","unstructured":"Behndig A, Cochener B, G\u00fcell JL, Kodjikian L, Mencucci R, Nuijts RMMA, et al. Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries. J Cataract Refract Surg. 2013;39:1421\u201331.","journal-title":"J Cataract Refract Surg"},{"key":"845_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ophtha.2015.09.037","volume":"123","author":"A Haripriya","year":"2016","unstructured":"Haripriya A, Chang DF, Namburar S, Smita A, Ravindran RD. Efficacy of Intracameral Moxifloxacin Endophthalmitis Prophylaxis at Aravind Eye Hospital. Ophthalmology. 2016;123:302\u20138.","journal-title":"Ophthalmology"},{"key":"845_CR20","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1097\/j.jcrs.0000000000000989","volume":"48","author":"AL Kunkler","year":"2022","unstructured":"Kunkler AL, Sengillo JD, Al-Khersan H, Fan KC, Laura DM, Miller D, et al. Acute-onset postoperative endophthalmitis after cataract surgery performed by resident and attending physicians at a university teaching hospital. J Cataract Refract Surg. 2022;48:1312\u20137.","journal-title":"J Cataract Refract Surg"},{"key":"845_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12348-020-00208-0","volume":"10","author":"VG Dimacali","year":"2020","unstructured":"Dimacali VG, Lim Bon Siong R. Infectious endophthalmitis at a Philippine tertiary hospital: a ten-year retrospective study. J Ophthalmic Inflamm Infect. 2020;10:19.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"845_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/08820538.2017.1353826","volume":"33","author":"S Rahmani","year":"2018","unstructured":"Rahmani S, Eliott D. Postoperative endophthalmitis: A review of risk factors, prophylaxis, incidence, microbiology, treatment, and outcomes. Semin Ophthalmol. 2018;33:95\u2013101.","journal-title":"Semin Ophthalmol"},{"key":"845_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/APO.0000000000000633","volume":"12","author":"T Das","year":"2023","unstructured":"Das T, Belenje A, Pandey S, Behera UC, Joseph J, Dave VP, et al. Endophthalmitis Management Study-A prospective randomized clinical trial on postoperative endophthalmitis management in India: An interim analysis. Endophthalmitis Management Study report #3. Asia Pac J Ophthalmol (Phila). 2023;12:437\u201343.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"845_CR24","first-page":"123","volume":"48","author":"AR Anand","year":"2000","unstructured":"Anand AR, Therese KL, Madhavan HN. Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates. Indian J Ophthalmol. 2000;48:123\u20138.","journal-title":"Indian J Ophthalmol"},{"key":"845_CR25","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2174\/1381612822666161208095348","volume":"23","author":"P Kuklo","year":"2017","unstructured":"Kuklo P, Grzybowski A, Schwartz SG, Flynn HW, Pathengay A. Hot topics in perioperative antibiotics for cataract surgery. Curr Pharm Des. 2017;23:551\u20137.","journal-title":"Curr Pharm Des"},{"key":"845_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/ph17030321","volume":"17","author":"N Garcia O\u2019Farrill","year":"2024","unstructured":"Garcia O\u2019Farrill N, Abi Karam M, Villegas VM, Flynn HW Jr, Grzybowski A, Schwartz SG. New approaches to overcoming antimicrobial resistance in endophthalmitis. Pharmaceuticals (Basel). 2024;17:321.","journal-title":"Pharmaceuticals (Basel)"},{"key":"845_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajo.2018.03.042","volume":"191","author":"C Chiquet","year":"2018","unstructured":"Chiquet C, Musson C, Aptel F, Boisset S, Maurin M. Genetic and phenotypic traits of Staphylococcus epidermidis strains causing postcataract endophthalmitis compared to commensal conjunctival flora. Am J Ophthalmol. 2018;191:76\u201382.","journal-title":"Am J Ophthalmol"},{"key":"845_CR28","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.ophtha.2015.03.016","volume":"122","author":"AJ Witkin","year":"2015","unstructured":"Witkin AJ, Shah AR, Engstrom RE, Kron-Gray MM, Baumal CR, Johnson MW, et al. Postoperative hemorrhagic occlusive retinal vasculitis: Expanding the clinical spectrum and possible association with vancomycin. Ophthalmology. 2015;122:1438\u201351.","journal-title":"Ophthalmology"},{"key":"845_CR29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ophtha.2016.11.042","volume":"124","author":"AJ Witkin","year":"2017","unstructured":"Witkin AJ, Chang DF, Jumper JM, Charles S, Eliott D, Hoffman RS, et al. Vancomycin-associated hemorrhagic occlusive retinal vasculitis: Clinical characteristics of 36 eyes. Ophthalmology. 2017;124:583\u201395.","journal-title":"Ophthalmology"},{"key":"845_CR30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.survophthal.2020.04.006","volume":"66","author":"A Grzybowski","year":"2021","unstructured":"Grzybowski A, Brona P, Zeman L, Stewart MW. Commonly used intracameral antibiotics for endophthalmitis prophylaxis: A literature review. Surv Ophthalmol. 2021;66:98\u2013108.","journal-title":"Surv Ophthalmol"},{"key":"845_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jcrs.2018.10.044","volume":"45","author":"MV Melega","year":"2019","unstructured":"Melega MV, Alves M, Cavalcanti Lira RP, Cardoso da Silva I, Ferreira BG, Assis Filho HL, et al. Safety and efficacy of intracameral moxifloxacin for prevention of post-cataract endophthalmitis: Randomized controlled clinical trial. J Cataract Refract Surg. 2019;45:343\u201350.","journal-title":"J Cataract Refract Surg"},{"key":"845_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5935\/0004-2749.20180022","volume":"81","author":"N Lucena","year":"2018","unstructured":"Lucena N, de Pereira P, de Gaete IM, Ferreira MIL, M\u00e9lega KSA, Lira MV. Intracameral moxifloxacin after cataract surgery: a prospective study. Arq Bras Oftalmol. 2018;81:92\u20134.","journal-title":"Arq Bras Oftalmol"},{"key":"845_CR33","doi-asserted-by":"crossref","unstructured":"Llovet-Rausell A, Llovet-Osuna F, Ortega-Usobiaga J, Beltran-Sanz J, Druchkiv V, editors. Acute postoperative endophthalmitis after phacoemulsification in a private ophthalmic surgical group. Arch Soc Esp Oftalmol (Engl Ed) [Internet]. 2024 [cited 2025 Mar 21]; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39642992\/.","DOI":"10.1016\/j.oftale.2024.07.012"},{"key":"845_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40942-025-00640-1","volume":"11","author":"VC Bergamo","year":"2025","unstructured":"Bergamo VC, Nakayama LF, de Moraes NSB, Tavares IM, De Queiroz Campos MS, Hofling-Lima AL, et al. Postoperative endophthalmitis treatment with antibiotics associated or not with pars plana vitrectomy: a randomized clinical trial. Int J Retina Vitreous. 2025;11:18.","journal-title":"Int J Retina Vitreous"},{"key":"845_CR35","doi-asserted-by":"crossref","unstructured":"Salha CP, Machado LN, Santos MSD. Efficacy of prophylactic intracameral antibiotic in preventing endophthalmitis after cataract surgery. Arq Bras Oftalmol [Internet]. 2024 [cited 2025 Mar 21];88. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39607157\/.","DOI":"10.5935\/0004-2749.2023-0345"},{"key":"845_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12348-025-00483-9","volume":"15","author":"K-Y Chen","year":"2025","unstructured":"Chen K-Y, Chan H-C, Chan C-M. Do people with diabetes have a higher risk of developing postoperative endophthalmitis after cataract surgery? A systematic review and meta-analysis. J Ophthalmic Inflamm Infect. 2025;15:24.","journal-title":"J Ophthalmic Inflamm Infect"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-026-00845-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:35:35Z","timestamp":1781645735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-026-00845-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["845"],"URL":"https:\/\/doi.org\/10.1186\/s40942-026-00845-y","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The university\u2019s Ethics Committee approved the study (number 0060\/2018), and informed consent was waived due to its retrospective nature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}